Under Sarbox, or Sarbanes Oxley, foreign shares listed on the NYSE, NASDAQ, or AMEX require an additional layer of accounting, CEO and CFO certifications, and audit committees. While well-intentioned, Sarbox has its costs. Recent data shows that for large US companies the cost of compliance averages $2.5 and $6 million per year. However, for foreign firms the costs are much higher and are estimated to be up to $12 million per year. Some of the best foreign companies have simply delisted, when costs outweigh the benefits. This is certainly not a positive thing for investors. Isn't the free movement of capital desirable, and shouldn't US investors have easy access to investing in foreign companies and vice versa? Below are a few of the companies that have delisted and their year to date returns. Some are available OTC:
BASF Corporation, Germany, +76%
Bayer AG, Germany, +75%
E.On AG, Germany, +76%
Volvo AB, Sweden, +26%
LaFarge Cement, France, +35%
Suez, France, +50%
Australia New Zealand Bank, Australia, +11%
National Australia Bank, Australia, +14%